Cash momentan um 70 Mio$ February 10, 2021 Common Shares outstanding 95,747,866 + https://app.quotemedia.com/data/...ateFiled=2021-02-18&CK=1113423
Warrants as at August 5, 2020
|
| Warrants |
|
| Exercise Price |
|
|
|
|
| # |
|
| $ |
|
| Expiry date | September 2019 registered direct offering |
|
| 3,325,000 |
|
|
| 1.65 |
|
| September 24, 2024 | February 2020 Financing |
|
| 2,608,696 |
|
|
| 1.20 |
|
| August 21, 2025 | February 2020 Financing |
|
| 243,478 |
|
|
| 1.61719 |
|
| February 19, 2025 | July 2020 Financing |
|
| 26,666,666 |
|
|
| 0.45 |
|
| July 7, 2025 | July 2020 Financing |
|
| 1,866,667 |
|
|
| 0.5625 |
|
| July 1, 2025 | August 2020 Financing |
|
| 9,320,907 |
|
|
| 0.47 |
|
| February 5, 2026 | August 2020 Financing |
|
| 869,952 |
|
|
| 0.7040625 |
|
| August 3, 2025 |
|
|
| 47,232,366 |
|
|
|
|
|
|
|
During the period beginning on January 1, 2021 and ending on February 10, 2021, investors have exercised certain of our outstanding warrants to purchase 33,069,253 of our common shares for gross proceeds of approximately $19.0 million (14.163.113)
Termine 2020:
6.April ------- Finale Ergebnisse PIP 01 (positive Results In Dose-finding)
15. Mai ------- Annual Meeting
25 Juni -------- Megapharm Distribution Agreement (ISRAEL AND THE PALESTINE) 7 Juli ----------- CLOSING OF $12 MILLION PUBLIC OFFERING 5.August -------- CLOSING OF $7 MILLION PUBLIC OFFERING 16.Nov ------------- Novo Lizenzdeal (Kompl. Rechte Mac US) 7. Dez. ------------- licensing agreement with Consilient Health, Ltd (Macrilen EU)
Termine 2021 13 Jan ------------ material transfer agreement with the University of Queensland (für THEeatenFISH. JA, MAC ALS MEDI!) ;-)))
25. Jan ----------- Nasdaq 1$ Regel (Ende erste 180 Tage) 28. Jan ---------- Expansion development pipeline with targeted immunosuppressive therapeutics 2 Feb. ----- Evaluation and potential development of an oral prophylactic bacterial vaccine against COVID-19 16 Feb. --------- Bought Deal Offering mit Weinright 29,7Mio$
18. Feb ----------- Nasdaq 1$ Regel mit 10 Tagen über 1$ erreicht
........ ---------- News 1$ Regel erledigt
Q1. ---------- geplant Anfang PIP 02
......... ---------- Q4 und Jahresabschl. 2020 ......... ---------- Q1 2021 COVID : Wir gehen davon aus, dass wir bis Mitte 2021 eine Entscheidung treffen werden
Termine 2022 Juli 2022------- geplant Ende PIP 02 min Q3 2023 ------------- AEterna mögliche EMA/FDA Zulassung pediatric US / EU
|